Cipla Q1 results: Net profit rises 27% to Rs 566 crore; beats Street expectations
Drugmaker Cipla reported a net profit of Rs 566.04 crore for the quarter ended June, an increase of 26.58% on the back of robust sales. In the same quarter a…
Drugmaker Cipla reported a net profit of Rs 566.04 crore for the quarter ended June, an increase of 26.58% on the back of robust sales. In the same quarter a…
India imports bulk drugs largely for economic reasons. Chinese bulk drugs are cheaper by 25-30 per cent on average, compared to domestic products. India to reduce over-dependence on Chinese pharmaceutical…